4-(5-(Trifluoromethyl)pyridin-2-yl)morpholine

Catalog No.: 
ACWZSV030
CAS No.: 
321679-59-8
Molecular Formula: 
C10H11F3N2O
Molecular Weight: 
232.21
4-(5-(Trifluoromethyl)pyridin-2-yl)morpholine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$445.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(5-(Trifluoromethyl)pyridin-2-yl)morpholine
IUPAC Name4-(5-(trifluoromethyl)pyridin-2-yl)morpholine
Molecular FormulaC10H11F3N2O
Molecular Weight232.21
SMILESFC(C1=CN=C(N2CCOCC2)C=C1)(F)F
InChI KeyGUJQKMWPUOKKPC-UHFFFAOYSA-N
Synonym4-(5-(trifluoroMethyl)pyridin-2-yl)Morpholine;Morpholine, 4-[5-(trifluoromethyl)-2-pyridinyl]-
CAS No.321679-59-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACWZSV030 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCPHV394 route compound structure diagram
    ACCPHV39450488-42-1In Stock
  4. Then
  5. ACWZSV030 route product structure diagram
    ACWZSV030321679-59-8
Inquiry

2. ACWZSV030 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFRZX973 route compound structure diagram
    ACFRZX97352334-81-3
  4. Then
  5. ACWZSV030 route product structure diagram
    ACWZSV030321679-59-8
Inquiry

3. ACWZSV030 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWZSV030 route product structure diagram
    ACWZSV030321679-59-8
Inquiry

Comments (0)